Matches in Wikidata for { <http://www.wikidata.org/entity/Q91889510> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q91889510 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91889510 description "bài báo khoa học" @default.
- Q91889510 description "scientific article published on 14 April 2020" @default.
- Q91889510 description "wetenschappelijk artikel" @default.
- Q91889510 description "наукова стаття, опублікована 14 квітня 2020" @default.
- Q91889510 name "Expanding the scope of antibody rebridging with new pyridazinedione-TCO constructs" @default.
- Q91889510 name "Expanding the scope of antibody rebridging with new pyridazinedione-TCO constructs" @default.
- Q91889510 type Item @default.
- Q91889510 label "Expanding the scope of antibody rebridging with new pyridazinedione-TCO constructs" @default.
- Q91889510 label "Expanding the scope of antibody rebridging with new pyridazinedione-TCO constructs" @default.
- Q91889510 altLabel "Expanding the Scope of Antibody Rebridging with New Pyridazinedione-TCO Constructs" @default.
- Q91889510 prefLabel "Expanding the scope of antibody rebridging with new pyridazinedione-TCO constructs" @default.
- Q91889510 prefLabel "Expanding the scope of antibody rebridging with new pyridazinedione-TCO constructs" @default.
- Q91889510 P1433 Q91889510-1A335B95-F998-4495-ACDE-274D8F2427DF @default.
- Q91889510 P1476 Q91889510-DCAAA98C-D450-445C-B612-84E79177CCF0 @default.
- Q91889510 P2093 Q91889510-3E589712-4F6C-495F-9E18-DBEEB9259BF0 @default.
- Q91889510 P2093 Q91889510-D2DBA329-54AB-4D53-9EBD-7372D50F56A1 @default.
- Q91889510 P2093 Q91889510-F31CC9D4-424C-4672-A347-725AC590F2FC @default.
- Q91889510 P2860 Q91889510-035C022D-00B2-44F3-9D2B-2412A9020378 @default.
- Q91889510 P304 Q91889510-8417BC05-8521-4686-9340-9DE6561E884E @default.
- Q91889510 P31 Q91889510-8A0C764F-C458-4770-BDAD-9AA19BA49417 @default.
- Q91889510 P356 Q91889510-FEFCB4E0-DF08-4BE2-B6AF-1BD9B32434AA @default.
- Q91889510 P407 Q91889510-AFAF9D21-306B-4BFD-95F6-9E7B76505E28 @default.
- Q91889510 P433 Q91889510-CE380171-CCC7-4E81-A49B-64ED6FEB2DC8 @default.
- Q91889510 P4510 Q91889510-F8BEEC11-2192-49CD-9D9D-AF1E8F7F3283 @default.
- Q91889510 P478 Q91889510-95C86B67-363E-43F8-997E-A9312199E6AB @default.
- Q91889510 P577 Q91889510-CC65ABE0-D95E-47AB-AA50-6862C81B0095 @default.
- Q91889510 P698 Q91889510-CF019F1D-B9CC-487C-A22A-E75F2CFBD952 @default.
- Q91889510 P932 Q91889510-AEA613EE-82EF-4AA9-9AB4-E3CB217DEFFF @default.
- Q91889510 P356 ACS.BIOCONJCHEM.0C00155 @default.
- Q91889510 P698 32286045 @default.
- Q91889510 P1433 Q2343023 @default.
- Q91889510 P1476 "Expanding the scope of antibody rebridging with new pyridazinedione-TCO constructs" @default.
- Q91889510 P2093 "Angela N Marquard" @default.
- Q91889510 P2093 "Jonathan C T Carlson" @default.
- Q91889510 P2093 "Ralph Weissleder" @default.
- Q91889510 P2860 Q35105725 @default.
- Q91889510 P304 "1616-1623" @default.
- Q91889510 P31 Q13442814 @default.
- Q91889510 P356 "10.1021/ACS.BIOCONJCHEM.0C00155" @default.
- Q91889510 P407 Q1860 @default.
- Q91889510 P433 "6" @default.
- Q91889510 P4510 Q1659584 @default.
- Q91889510 P478 "31" @default.
- Q91889510 P577 "2020-04-14T00:00:00Z" @default.
- Q91889510 P698 "32286045" @default.
- Q91889510 P932 "7788567" @default.